Literature DB >> 30366846

Implications of blood group on lung transplantation rates: A propensity-matched registry analysis.

Yaron D Barac1, Mike S Mulvihill1, Morgan L Cox1, Muath Bishawi1, Jacob Klapper1, John Haney1, Mani Daneshmand1, Matthew G Hartwig2.   

Abstract

BACKGROUND: Blood type O lung allografts may be allocated to blood type identical (type O) or compatible (non-O) candidates. We tested the hypothesis that the current organ allocation schema in the United States-based on the Lung Allocation Score-prejudices against the allocation of allografts to type O candidates, given that the pool of potential donors is smaller.
METHODS: We performed a retrospective cohort review of the Organ Procurement and Transplantation Network/United Network of Organ Sharing registry from May 2005 to March 2017 for adult candidates on the waiting list for first-time isolated lung transplantation. Demographic data were compiled and described, and 1:1 nearest-neighbor propensity score matching was used to adjust for age and Lung Allocation Score at listing.
RESULTS: A total of 26,396 candidates met inclusion criteria: 14,329 type non-O and candidates and 12,068 type O candidates. After matching, 11,951 candidates were included in each group. Of these, 77.0% of type non-O underwent lung transplantation vs 73.1% type O (p < 0.001). At 1 year, the waiting list mortality was higher for type O candidates (12.5%) than for non-O candidates (10.1%, p < 0.001). Of those undergoing transplantation, 5-year survival rates were similar.
CONCLUSIONS: Type O candidates experience lower rates of transplantation and higher rates of waiting list mortality compared with matched type non-O candidates. Further evaluation of regional sharing of allografts to increase transplantation rates for type O candidates may be warranted to optimize equity in access to transplants.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  blood type O; donor pool; lung allografts; organ allocation system; waiting list mortality

Mesh:

Substances:

Year:  2018        PMID: 30366846      PMCID: PMC7051827          DOI: 10.1016/j.healun.2018.09.013

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  Influence of blood group on mortality and waiting time before heart transplantation in the United kingdom: implications for equity of access.

Authors:  J C Hussey; J Parameshwar; N R Banner
Journal:  J Heart Lung Transplant       Date:  2007-01       Impact factor: 10.247

Review 2.  Lung and heart allocation in the United States.

Authors:  M Colvin-Adams; M Valapour; M Hertz; B Heubner; K Paulson; V Dhungel; M A Skeans; L Edwards; V Ghimire; C Waller; W S Cherikh; B L Kasiske; J J Snyder; A K Israni
Journal:  Am J Transplant       Date:  2012-09-13       Impact factor: 8.086

3.  Effect of the lung allocation score on lung transplantation in the United States.

Authors:  Thomas M Egan; Leah B Edwards
Journal:  J Heart Lung Transplant       Date:  2016-01-15       Impact factor: 10.247

4.  Examining ABO compatible donors in double lung transplants during the era of lung allocation score.

Authors:  Sharven Taghavi; Senthil N Jayarajan; Yuka Furuya; Eugene Komaroff; Akira Shiose; Eros Leotta; Kazuhiro Hisamoto; Namrata Patel; Francis Cordova; Gerard Criner; T Sloane Guy; Yoshiya Toyoda
Journal:  Ann Thorac Surg       Date:  2014-08-05       Impact factor: 4.330

5.  Single-lung transplantation with ABO-compatible donors results in excellent outcomes.

Authors:  Sharven Taghavi; Senthil N Jayarajan; Yuka Furuya; Eugene Komaroff; Akira Shiose; Eros Leotta; Kazuhiro Hisamoto; Namrata Patel; Francis Cordova; Gerard Criner; T Sloane Guy; Yoshiya Toyoda
Journal:  J Heart Lung Transplant       Date:  2014-04-19       Impact factor: 10.247

6.  From 6 years to 5 days for organ allocation policy change.

Authors:  Thomas M Egan
Journal:  J Heart Lung Transplant       Date:  2017-12-20       Impact factor: 10.247

7.  OPTN/SRTR 2016 Annual Data Report: Lung.

Authors:  M Valapour; C J Lehr; M A Skeans; J M Smith; R Carrico; K Uccellini; R Lehman; A Robinson; A K Israni; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2018-01       Impact factor: 8.086

8.  ABO-incompatible living-donor lobar lung transplantation.

Authors:  Tsuyoshi Shoji; Toru Bando; Takuji Fujinaga; Fengshi Chen; Kimiko Yurugi; Taira Maekawa; Hiroshi Date
Journal:  J Heart Lung Transplant       Date:  2010-12-18       Impact factor: 10.247

9.  Development of the new lung allocation system in the United States.

Authors:  T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

10.  Lessons and insights from ABO-incompatible lung transplantation.

Authors:  G I Snell; M Holmes; B J Levvey; A Shipp; C Robertson; G P Westall; S Cohney
Journal:  Am J Transplant       Date:  2013-03-06       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.